Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol 2014; 32: 2416-2422.

Published: 5th February 2015

Authors: Mariette C, Dahan L, Mornex F, Maillard E, Thomas P-A, Meunier B et al. et al.


In this trial that included 195 patients followed for a median of 94 months, three-year survival after chemoradiotherapy (47.5 per cent) was similar to that after surgery alone (53 per cent). The trial was stopped for futility.

Pubmed Link

Your comments